M&A Deal Summary

LifeNet Health Acquires Vivo Biosciences

On November 2, 2016, LifeNet Health acquired life science company Vivo Biosciences

Acquisition Highlights
  • This is LifeNet Health’s 1st transaction in the Life Science sector.
  • This is LifeNet Health’s 1st transaction in the United States.
  • This is LifeNet Health’s 1st transaction in Alabama.

M&A Deal Summary
Date 2016-11-02
Target Vivo Biosciences
Sector Life Science
Buyer(s) LifeNet Health
Deal Type Add-on Acquisition

Target

Vivo Biosciences

Birmingham, Alabama, United States
Vivo Biosciences, Inc. is a developer of a patented "all-human" bioassay platform, HuBiogel, which allows for rapid analysis of drug efficacy, toxicity and therapy prediction in the preclinical research, drug discovery and therapeutics markets.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

LifeNet Health

Virginia Beach, Virginia, United States
Category Company
Sector Healthcare Services
DESCRIPTION

LifeNet Health is a provider of transplant solutions from organ procurement to bio-implants and cellular therapies and a leader in regenerative medicine, while always honoring the donors and healthcare professionals who enable healing.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (Alabama) 1 of 1
Country (United States) 1 of 2
Year (2016) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-07 Samsara Sciences

San Diego, California, United States

Samsara Sciences is a San Diego-based life sciences company specializing in human primary liver and kidney cell isolation.

Buy -
Mergr

Product

Company

Legal